Daridorexant for Alzheimer Disease Prevention

Clinical trial NCT07213349 · RECRUITING

Trial details

NCT number: NCT07213349
Sponsor: Douglas Mental Health University Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease (AD)

Start date: 2025-10-14
Primary completion: 2028-12-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.